These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323 [TBL] [Abstract][Full Text] [Related]
3. 30-Day Clinical Outcomes of a Self-Expanding Transcatheter Aortic Valve: The International PORTICO NG Study. Reardon MJ; Chehab B; Smith D; Walton AS; Worthley SG; Manoharan G; Sultan I; Yong G; Harrington K; Mahoney P; Kleiman N; Makkar RR; Fontana G; DeLago A; Ramana RK; Bates N; Søndergaard L JACC Cardiovasc Interv; 2023 Mar; 16(6):681-689. PubMed ID: 36990558 [TBL] [Abstract][Full Text] [Related]
4. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family. Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study. Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998 [TBL] [Abstract][Full Text] [Related]
6. 1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve. Tchétché D; Windecker S; Kasel AM; Schaefer U; Worthley S; Linke A; Abdel-Wahab M; Le Breton H; Søndergaard L; Spence MS; Petronio S; Baumgartner H; Hovorka T; Blanke P; Reichenspurner H JACC Cardiovasc Interv; 2019 Apr; 12(7):673-680. PubMed ID: 30947942 [TBL] [Abstract][Full Text] [Related]
7. Improved transfemoral accessibility and positioning of the Portico transcatheter heart valve with the new FlexNav delivery system. Casenghi M; Rubbio AP; Marco F; Brambilla N; Agnifili M; Testa L; Bedogni F Future Cardiol; 2021 Jul; 17(4):619-624. PubMed ID: 33599132 [TBL] [Abstract][Full Text] [Related]
8. Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study. Sondergaard L; Walton AS; Worthley SG; Smith D; Chehab B; Manoharan G; Yong G; Bedogni F; Bates N; Reardon MJ EuroIntervention; 2023 Jun; 19(3):248-255. PubMed ID: 36895190 [TBL] [Abstract][Full Text] [Related]
9. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832 [TBL] [Abstract][Full Text] [Related]
10. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. Popma JJ; Reardon MJ; Khabbaz K; Harrison JK; Hughes GC; Kodali S; George I; Deeb GM; Chetcuti S; Kipperman R; Brown J; Qiao H; Slater J; Williams MR JACC Cardiovasc Interv; 2017 Feb; 10(3):268-275. PubMed ID: 28183466 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. Manoharan G; Walton AS; Brecker SJ; Pasupati S; Blackman DJ; Qiao H; Meredith IT JACC Cardiovasc Interv; 2015 Aug; 8(10):1359-1367. PubMed ID: 26315740 [TBL] [Abstract][Full Text] [Related]
12. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. Forrest JK; Mangi AA; Popma JJ; Khabbaz K; Reardon MJ; Kleiman NS; Yakubov SJ; Watson D; Kodali S; George I; Tadros P; Zorn GL; Brown J; Kipperman R; Saul S; Qiao H; Oh JK; Williams MR JACC Cardiovasc Interv; 2018 Jan; 11(2):160-168. PubMed ID: 29348010 [TBL] [Abstract][Full Text] [Related]
13. 30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve: The Hydra CE Study. Aidietis A; Srimahachota S; Dabrowski M; Bilkis V; Buddhari W; Cheung GSH; Nair RK; Mussayev AA; Mattummal S; Chandra P; Mahajan AU; Chmielak Z; Govindan SC; Jose J; Hiremath MS; Chandra S; Shetty R; Mohanan S; John JF; Mehrotra S; Søndergaard L JACC Cardiovasc Interv; 2022 Jan; 15(1):93-104. PubMed ID: 34991828 [TBL] [Abstract][Full Text] [Related]
14. 30-Day Outcomes With the Portico Transcatheter Heart Valve: Insights From a Multi-Centre Australian Observational Study. Camuglia AC; Cole CMW; Boyne N; Hayman SM; Cox SV; Moore PT; Lau JK; Delacroix S; Williamson AE; Duong M; Schwarz N; Montarello JK; Worthley SG Heart Lung Circ; 2023 Feb; 32(2):224-231. PubMed ID: 36344392 [TBL] [Abstract][Full Text] [Related]